Sodium Phosphates (Cardinal Health)
Welcome to the PulseAid listing for the Sodium Phosphates drug offered from Cardinal Health. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cardinal Health |
| NON-PROPRIETARY NAME: | sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic anhydrous |
| SUBSTANCE NAME: | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 1990-09-30 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Phosphates HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Phosphates from Cardinal Health |
| LABELER NAME: | Cardinal Health |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 276; 142(mg/mL; mg/mL) |
| START MARKETING DATE: | 1990-09-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55154-5738_3d066575-f361-4fcc-b1f3-3ae2be447719 |
| PRODUCT NDC: | 55154-5738 |
| APPLICATION NUMBER: | |
Other SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Pharmaceutical Manufacturers / Labelers:
